Martell Christopher
- SEC CIK
- 0001873465
No open-market purchases or sales filed in the past year.
Current role at each company
- CADL Candel Therapeutics, Inc.Directoras of Jun 24, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Martell Christopher as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 (view filing) | Dec 8-9, 2022 | 71 days | Martell ChristopherDirector | PPurchase | +27.0K | $1.89 | +$51.1K | +21.6%152.0K after | Amended2 lots |
| Aug 2, 2021 (view filing) | Jul 29 | 4 days | Martell ChristopherDirector | PPurchase | +125.0K | $8.00 | +$1.00M | New position125.0K after |